UTime Limited Class A Ordinary Shares
WTOUTime Limited is a technology company that specializes in the development, manufacturing, and distribution of smartwear, wearable devices, and related electronic products. The company focuses on integrating advanced technology into consumer electronics to enhance lifestyle and health management. Its operations often involve innovation in related digital and electronic product sectors.
Company News
Univest Securities successfully closed a $1.2 million registered direct offering for UTime Limited, selling 1 million Class A ordinary shares at $1.20 per share to institutional investors. Univest acted as the sole placement agent for the offering, which was conducted under a previously effective shelf registration statement.
UTime Limited (Nasdaq: WTO), a mobile devices and smart hardware manufacturer, announced a registered direct offering of 1,000,000 Class A ordinary shares at $1.20 per share, expected to raise approximately $1.2 million gross proceeds. The offering is expected to close on or about May 4, 2026, with Univest Securities serving as the sole placement...
UTime Limited (NASDAQ: WTO) announced a nonbinding letter of intent to acquire 100% of Feixiaohao Technology Inc. for up to $80 million ($64 million in stock and $16 million in cash). The acquisition aims to enhance UTime's position in the Web3 and blockchain data infrastructure sector by integrating Feixiaohao's data capabilities with UTime's ha...
UTime Limited's subsidiary Shenzhen Liandai Technology has signed a strategic intent agreement with Shenzhen Yunwei Digital Technology for the potential supply of 500,000 units of GM800 smart servers valued at approximately $50 million. The agreement marks UTime's expansion into the enterprise and cloud infrastructure sector, with formal contract...
UTime Limited's Hong Kong subsidiary signed a ~$10 million procurement agreement with Tumu Vertex LLC for 50,000 smart health devices, including blood pressure watches and ECG smart rings. The order marks UTime's strategic expansion into the North American medical-grade wearable market, with initial deliveries expected in Q1 2026.
